Latest Insider Transactions at Enfusion, Inc. (ENFN)
This section provides a real-time view of insider transactions for Enfusion, Inc. (ENFN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Enfusion, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Enfusion, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 25
2023
|
Lawrence E Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,238
+9.13%
|
-
|
|
Apr 25
2023
|
Dan Groman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,219
-8.86%
|
$73,752
$8.33 P/Share
|
|
Apr 25
2023
|
Dan Groman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,974
+17.43%
|
-
|
|
Apr 17
2023
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,877
-4.51%
|
$34,893
$9.66 P/Share
|
|
Mar 24
2023
|
Tarek Hammoud > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,000,000
+49.99%
|
-
|
|
Mar 17
2023
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,877
-4.31%
|
$38,770
$10.94 P/Share
|
|
Mar 08
2023
|
Tarek Hammoud > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,870,000
-76.71%
|
$18,700,000
$10.9 P/Share
|
|
Mar 08
2023
|
Stephen Malherbe > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,000
-100.0%
|
$11,000,000
$11.35 P/Share
|
|
Feb 17
2023
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,877
-4.14%
|
$38,770
$10.93 P/Share
|
|
Feb 16
2023
|
Stephen Malherbe > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,000,000
+50.0%
|
-
|
|
Jan 25
2023
|
Steven M. Bachert Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,632
-4.82%
|
$105,952
$11.88 P/Share
|
|
Jan 25
2023
|
Steven M. Bachert Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,739
+15.16%
|
-
|
|
Jan 25
2023
|
Bronwen Bastone Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
218
-0.13%
|
$2,398
$11.88 P/Share
|
|
Jan 25
2023
|
Bronwen Bastone Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
638
+0.39%
|
-
|
|
Jan 25
2023
|
Lawrence E Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,238
+10.04%
|
-
|
|
Jan 25
2023
|
Dan Groman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,219
-8.95%
|
$101,409
$11.88 P/Share
|
|
Jan 25
2023
|
Dan Groman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,976
+17.59%
|
-
|
|
Jan 25
2023
|
Lorelei M. Skillman Chief Mrktg. & Comm. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.39%
|
$2,024
$11.88 P/Share
|
|
Jan 25
2023
|
Lorelei M. Skillman Chief Mrktg. & Comm. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
483
+1.02%
|
-
|
|
Jan 23
2023
|
Lorelei M. Skillman Chief Mrktg. & Comm. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,382
-6.82%
|
$40,584
$12.05 P/Share
|
|
Jan 17
2023
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,877
-4.57%
|
$38,770
$10.93 P/Share
|
|
Jan 10
2023
|
Dan Groman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,190
-27.5%
|
$354,090
$11.26 P/Share
|
|
Jan 09
2023
|
Michael Spellacy Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,341
+32.8%
|
-
|
|
Jan 09
2023
|
Deirdre Somers Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,313
+34.13%
|
-
|
|
Jan 05
2023
|
Dan Groman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,651
+4.61%
|
-
|
|
Jan 05
2023
|
Lorelei M. Skillman Chief Mrktg. & Comm. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,521
+8.35%
|
-
|
|
Jan 05
2023
|
Oleg Movchan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,604
+7.66%
|
-
|
|
Jan 05
2023
|
Bradley Herring Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,688
+15.87%
|
-
|
|
Jan 05
2023
|
Bronwen Bastone Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,651
+3.35%
|
-
|
|
Dec 27
2022
|
Kathleen De Rose Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,791
+8.02%
|
-
|
|
Dec 22
2022
|
Oleg Movchan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+50.0%
|
-
|
|
Dec 19
2022
|
Bradley Herring Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
175,000
+50.0%
|
-
|
|
Nov 17
2022
|
Tarek Hammoud > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,870,386
+50.0%
|
-
|
|
Nov 15
2022
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
5,103
-4.38%
|
$71,442
$14.06 P/Share
|
|
Nov 14
2022
|
Steven M. Bachert Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
26,000
-13.67%
|
$338,000
$13.69 P/Share
|
|
Nov 14
2022
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
7,000
-5.67%
|
$91,000
$13.69 P/Share
|
|
Nov 11
2022
|
Tarek Hammoud > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,000
-100.0%
|
$12,000,000
$12.15 P/Share
|
|
Oct 25
2022
|
Dan Groman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,923
-4.58%
|
$76,999
$13.3 P/Share
|
|
Oct 25
2022
|
Dan Groman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,976
+14.52%
|
-
|
|
Oct 25
2022
|
Stephen M Dorton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,355
-4.6%
|
$134,615
$13.3 P/Share
|
|
Oct 25
2022
|
Stephen M Dorton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,423
+14.58%
|
-
|
|
Oct 25
2022
|
Lawrence E Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,239
+11.16%
|
-
|
|
Oct 25
2022
|
Lorelei M. Skillman Chief Mrktg. & Comm. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.41%
|
$2,392
$13.3 P/Share
|
|
Oct 25
2022
|
Lorelei M. Skillman Chief Mrktg. & Comm. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
483
+1.06%
|
-
|
|
Oct 25
2022
|
Steven M. Bachert Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,632
-4.82%
|
$125,216
$13.3 P/Share
|
|
Oct 25
2022
|
Steven M. Bachert Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,739
+15.17%
|
-
|
|
Oct 25
2022
|
Bronwen Bastone Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-0.14%
|
$2,808
$13.3 P/Share
|
|
Oct 25
2022
|
Bronwen Bastone Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
639
+0.4%
|
-
|
|
Oct 17
2022
|
Tarek Hammoud > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,000,000
+50.0%
|
-
|
|
Aug 12
2022
|
Oleg Movchan Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
400,000
+50.0%
|
-
|